未登录First-in-human phase 1/1b trial of the first-in-class bi-steric mTORC1-selective inhibitor RMC-5552 in patients with advanced solid tumors
Schram, Alison M.; Nagash, Abdul Rafeh; Haura, Eric B.; Riess, Jonathan W.; Ulahannan, Susanna V.; Ou, Sai-Hong I.; Capasso, Anna; Munster, Pamela N.; Cheng, Michael L.; Gustafson, W. Clay; Bitman, Bojena; Kar, Sumit; Wang, Zhican; Tao, Lin; Meyerowitz, Justin G.; Burns, Howard A.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏